BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Myositis Support and Understanding - ECPv6.15.17//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://understandingmyositis.org
X-WR-CALDESC:Events for Myositis Support and Understanding
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230718T190000
DTEND;TZID=America/New_York:20230718T200000
DTSTAMP:20260419T063145
CREATED:20230710T143934Z
LAST-MODIFIED:20230710T143934Z
UID:10001398-1689706800-1689710400@understandingmyositis.org
SUMMARY:The MINT Clinical Trial for Myositis Patients with Interstitial Lung Disease
DESCRIPTION:[vc_row padding_top=”20″ padding_bottom=”30″][vc_column][vc_column_text] \nJoin Dr. Rohit Aggarwal and MSU for a webinar about The MINT Clinical Trial for Myositis Patients with Interstitial Lung Disease!\nTuesday\, July 18th at 7 PM ET / 6 PM CT / 5 PM MT / 4 PM PT \nIf you have been diagnosed with pulmonary fibrosis\, also known as Interstitial Lung Disease (ILD)\, and you also have myositis (such as polymyositis\, dermatomyositis\, or anti-synthetase syndrome) or positive myositis autoantibodies\, you may be eligible to take part in a research study called MINT. \nThe goal of this study is to gain a better understanding of how anti-fibrotic drugs can help treat myositis associated with ILD. The study will focus on the drug Nintedanib (brand name Ofev®)\, an oral anti-fibrotic medication approved by the Food and Drug Administration (FDA) for the treatment of various types of ILD. \nThe exciting part is that this clinical trial is unique because you won’t need to visit a study center. You can participate in the study from the comfort of your own home. No need to worry about traveling long distances or spending time away from your surroundings. \nIs this study right for you? Join the webinar to find out and have all of your questions answered.[/vc_column_text] Click to Register on Zoom[/vc_column][/vc_row]
URL:https://understandingmyositis.org/event/mint-clinical-trial-myositis-interstitial-lung-disease/
LOCATION:MSU Zoom Video Session\, Video session using Zoom
CATEGORIES:Video Session
ATTACH;FMTTYPE=image/png:https://understandingmyositis.org/wp-content/uploads/2023/07/MINT-Webinar-5.png
ORGANIZER;CN="Myositis Support and Understanding (MSU)":MAILTO:info@UnderstandingMyositis.org
END:VEVENT
END:VCALENDAR